VAUGHAN, ONJune 5, 2018 /CNW/ – CannTrust Holdings Inc. (TSX: TRST) (“CannTrust” or the “Company“), a licensed producer of medical cannabis under the Health Canada Access to Cannabis for Medical Purposes Regulation (“ACMPR“) program, today announced that it has closed its previously announced short form prospectus offering, on a bought deal basis, including the full exercise of the over-allotment option.  A total of 11,155,000 units of the Company (“Units“) were sold at a price of $9.00 per Unit for aggregate gross proceeds of $100,395,000 (the “Offering“).

Read the full press release here.